Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

Mohammad Munshi; Alexandra Junge; Karolina Gadaldi; Nikhil Yawalkar; Kristine Heidemeyer

doi:10.1016/j.jdcr.2020.05.014

Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

JAAD Case Rep. 2020 May 17;6(7):634-636. doi: 10.1016/j.jdcr.2020.05.014. eCollection 2020 Jul.

Authors

Mohammad Munshi¹, Alexandra Junge¹, Karolina Gadaldi¹, Nikhil Yawalkar¹, Kristine Heidemeyer¹

Affiliation

¹ Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

No abstract available

Keywords: AGEP, acute generalized exanthematous pustulosis; IL, interleukin; acute generalized exanthematous pustulosis; hydroxychloroquine; ixekizumab.

Publication types

Case Reports